Navigation Links
CEL-SCI Corporation Releases Letter to Shareholders
Date:2/20/2009

ale following approval. We have also designed the facility to be used as a contract manufacturing facility during those times (e.g., during certain times in the Phase III study) when we will not be producing Multikine. This lucrative business could quickly become a multi-million dollar revenue generator for CEL-SCI.

  • We presented very promising data on a new rheumatoid arthritis vaccine discovered by CEL-SCI scientists. The data presented was as good as that achieved with Enbrel, a leading treatment for rheumatoid arthritis.

  • We started planning and pricing our global clinical trial designed to lead to marketing approval for Multikine. The recent strength of the dollar will reduce our Phase III study costs by several million dollars.

While we are pleased by these accomplishments, we also recognize that there are major challenges due to the severe financial downturn. This downturn has affected all of us, but we have taken immediate action. We very quickly reduced our expenditures and expanded our discussions with various pharmaceutical companies for a world-wide Multikine partnership. Things are very difficult all around for most companies, but we are seeing new strength in the bigger biotechnology names. This will hopefully trickle down to the smaller ones like us as well. The huge buyouts in the industry, Pfizer buying Wyeth and Roche trying to buy Genentech, will add over $100 billion in liquidity to the industry, and that too should help us down the road.

Let me share with you how we at CEL-SCI are dealing with and planning for recovery from this financial downturn. In our opinion, during such a difficult time as this you cannot rely on one strategy alone. Therefore we are pursuing the following multi-pronged strategy. To
'/>"/>

SOURCE CEL-SCI Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. CEL-SCI Announces Expansion of Exclusive Licensing Agreement for Cancer Drug Multikine
2. CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect
3. CEL-SCI Expects to Take Delivery of New Manufacturing Facility on October 8, 2008
4. Data Suggest CEL-SCIs CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis
5. CEL-SCI Corporation Reports First Quarter Financial Results
6. CEL-SCI Corporation Announces 2007 Financial Results
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
8. CEL-SCI to Present at Rodman & Renshaw 9th Annual Healthcare Conference
9. CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase
10. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
11. CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... 20 de octubre de 2014  PneumRx, Inc. ... de la pulmonología intervencional, anunció hoy la conclusión ... 3 meses antes de lo programado. El Estudio Clínico ... dispositivo de investigación (IDE) aprobada por la FDA ... de espiral de reducción de volumen pulmonar PneumRx ...
(Date:10/20/2014)... Oct. 20, 2014  ResMed (NYSE: ... ResMed Data Exchange program, a comprehensive suite of ... (HME) and other health care providers. ... to critical patient information. It integrates valuable sleep ... U-Sleep™ patient management platforms with customers, in-house or ...
(Date:10/20/2014)... 2014  AnaptysBio, Inc., a leader in the ... the appointment of Marco Londei , M.D. ... the preclinical and clinical development of AnaptysBio,s proprietary ... to welcome Dr. Londei to AnaptysBio,s executive leadership ... Chief Executive Officer of AnaptysBio. "Dr. Londei,s extensive ...
Breaking Medicine Technology:PneumRx concluye inscripción en prueba fundamental RENEW 2PneumRx concluye inscripción en prueba fundamental RENEW 3ResMed Launches ResMed Data Exchange 2AnaptysBio Appoints Dr. Marco Londei to Newly Created Chief Development Officer Position Clinical Immunologist to Lead AnaptysBio's Pipeline Advancement 2
... 9, 2012  Medical Director for WAISMANN METHOD® rapid ... Michael Lowenstein, announced his support for National Fibromyalgia Awareness ... number of fibromyalgia patients are being prescribed opiate painkillers ... to Dr. Lowenstein as prescription painkiller use is also ...
... 8, 2012  Coloplast North America today announced that a ... Medical Devices, Inc. (GMD) was infringing on a Coloplast ... treating stress urinary incontinence in women. Using this approach, ... women regain control of their bladder. The ...
Cached Medicine Technology:WAISMANN METHOD® Medical Director Voices Support for Fibromyalgia Awareness Day 2Coloplast Wins Patent Infringement Verdict Against Generic Medical Devices, Inc. 2
(Date:10/22/2014)... October 22, 2014 For Dr. Iris Hunter, ... money; it’s an extension of her life’s mission. Her extensive ... as the owner of FirstLight HomeCare, make it clear that ... to me that my work makes a difference in the ... entrepreneurial spirit, so after much research, I felt ready to ...
(Date:10/22/2014)... California (PRWEB) October 22, 2014 Hay House ... Move Beyond Addiction and Upgrade Your Life (Paperback; $10.82) written ... of Yoga & Recovery. This book is meant to ... in a life of recovery. , Recovery 2.0 is ... 12 Steps; Recovery 2.0 is a guide for what comes ...
(Date:10/22/2014)... (PRWEB) October 22, 2014 Losing Weight Your ... industry is staring you in the face, it certainly can ... not do your body an extra favor by doing it ... tempting crash diets. Instead, listen to your body, exercise regularly, ... Exercise is essential to losing weight; you need to exercise ...
(Date:10/22/2014)... Steven Reinberg HealthDay Reporter ... quickly add weight and length may be showing a genetic ... In adults, certain genes have been linked to increased body ... in fat and lean muscle, the researchers said. At ... taller. By ages 2 and 3, however, these genes were ...
(Date:10/22/2014)... (HealthDay News) -- Measures taken by Firestone officials at ... may have limited the spread of the disease there ... Firestone Natural Rubber Co. provides health services to about ... densely populated communities. Between Aug. 1 and Sept. ... among those 80,000 people. That incidence rate of 0.09 ...
Breaking Medicine News(10 mins):Health News:Dr. Iris Hunter to Host Grand Opening of FirstLight HomeCare Tomorrow 2Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 2Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 3Health News:ReductionGuruMD Presents Ways to Improve Your Weight Loss Results 2Health News:Tall, Heavy 1-Year-Olds May Be at Risk for Obesity Later, Study Finds 2Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2
... impair the cognitive health of people, but now scientists ... memory problems. A new National Institutes of Health ... of a stress hormone produced by the adrenal gland ... of the brain responsible for learning and short-term memory. ...
... professor of psychiatry and human behavior at The Warren Alpert ... Control & Diabetes Research Center at The Miriam Hospital, people ... who lose weight and keep the pounds off, have made ... Using new research findings, Wing will make her case for ...
... Drug-Resistant Killers of the 21st Century , WHO: , ... Thomas Lietman, University of California, San Francisco , ... State University , Peter Small, Bill and Melinda ... Ramanan Laxminarayan, Resources for the Future , ...
... is crucial to understanding psychosis, but there is more ... Arizona State University bioethicist and philosopher of science. , ... complexity of classification and diagnosis, Robert explains. But I ... psychiatrist often ill, unhappy people who behave in ...
... National Osteoporosis Foundation, osteoporosis affects some 25 million Americans ... causes a thinning of the bone, it can lead ... of debilitating and sometimes deadly complications. , Bisphosphonates (BFs), ... class of drugs that act to prevent bone fractures ...
... ... WASHINGTON, Feb. 16 As President Bush begins,a five-country tour ... Emergency Plan for AIDS Relief (PEPFAR), the five year-old US,global ... (AHF) ( http://www.aidshealth.org ) today cautioned the President,that his legacy ...
Cached Medicine News:Health News:Stress hormone impacts memory, learning in diabetic rodents 2Health News:Large changes needed to address global obesity epidemic 2Health News:Arizona State bioethicist says mental illness is subject to biological and sociocultural factors 2Health News:Arizona State bioethicist says mental illness is subject to biological and sociocultural factors 3Health News:Link between treating osteoporosis with bisphosphonates and incidence of bone necrosis examined 2Health News:Bush AIDS Legacy at Risk, Says AHF 2
... Mouthpiece 7FT O 2 Tubing Tee Adapter, ... for fast treatment times , ... (higher percentage of respirable particles) than conventional nebulizers, ... Max 10™ disposable nebulizers deliver fast and effective ...
Nebulizer Custom Kit...
... Anesthesia and Respiratory Products, ,Westmed designs, ... for Anesthesia and Respiratory professionals. Our mission ... enhance the clinician's ability to deliver quality ... the bottom line. , ,Our web ...
... Products, ,Westmed designs, manufacturers and markets ... Respiratory professionals. Our mission is to design ... ability to deliver quality medical care while ... , ,Our web site is designed ...
Medicine Products: